Cancer
LY6K 177-186 (HLA-A*24:02) RYCNLEGPPI
Product number: EP11340_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide LY6K 177-186 (HLA-A*24:02) with the amino acid sequence RYCNLEGPPI is a linear peptidic epitope (epitope ID 767706) studied as part of Lymphocyte antigen 6K (UniProt:Q17RY6) from Homo sapiens (human).
LY6K 177-186 (HLA-A*24:02) has been studied for immune reactivity in publications and has been tested in T cell assays and MHC ligand assay.
TechData
| Sequence: | RYCNLEGPPI |
| Gene: | LY6K |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Lymphocyte antigen 6K |
| Species: | Human |
| Allele: | HLA-A*24:02 |
| Application: | Flow Cytometry, Immunohistochemistry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |